Control vs 0 days |
Lymphocyte chemotaxis (GO:0048247) |
34 |
8 |
69.26 |
5.14E−09 |
Adam8, Ccl2, Cxcl16, Cxcl11, Ccl12, Ccl7, Ccl22, Ccl17 |
T cell migration (GO:0072678) |
19 |
4 |
61.97 |
6.73E−03 |
Ccl2, Cxcl16, Cxcl11, Itgb7 |
Lymphocyte migration (GO:0072676) |
45 |
9 |
58.87 |
7.12E−10 |
Adam8, Ccl2, Cxcl16, Cxcl11, Ccl12, Ccl7, Itgb7, Ccl22, Ccl17 |
Monocyte chemotaxis (GO:0002548) |
30 |
6 |
58.87 |
1.24E−05 |
Anxa1, Ccl2, Ccl12, Ccl7, Ccl22, Ccl17 |
Mononuclear cell migration (GO:0071674) |
33 |
6 |
53.52 |
2.18E−05 |
Anxa1, Ccl2, Ccl12, Ccl7, Ccl22, Ccl17 |
Granulocyte chemotaxis (GO:0071621) |
65 |
7 |
31.7 |
3.38E−05 |
Anxa1, Ccl2, Spp1, Ccl12, Ccl7, Ccl22, Ccl17 |
Neutrophil chemotaxis (GO:0030593) |
58 |
6 |
30.45 |
6.00E−04 |
Ccl2, Spp1, Ccl12, Ccl7, Ccl22, Ccl17 |
Granulocyte migration (GO:0097530) |
71 |
7 |
29.02 |
6.17E−05 |
Anxa1, Ccl2, Spp1, Ccl12, Ccl7, Ccl22, Ccl17 |
Chemokine-mediated signaling pathway (GO:0070098) |
61 |
6 |
28.95 |
8.05E−04 |
Ccl2, Cxcl11, Ccl12, Ccl7, Ccl22, Ccl17 |
Neutrophil migration (GO:1990266) |
63 |
6 |
28.03 |
9.72E−04 |
Ccl2, Spp1, Ccl12, Ccl7, Ccl22, Ccl17 |
|
Control vs 3 days |
|
Regulation of chromosome segregation (GO:0051983) |
86 |
6 |
19.99 |
6.93E−03 |
Ube2c, Dusp1, Pttg1, Knstrn, Bub1b, Spag |
Mitotic sister chromatid segregation (GO:0000070) |
95 |
6 |
18.1 |
1.23E−02 |
Aurk, Pttg1, Knstrn, Kiff22, Cxc20, Spag5 |
Mitotic nuclear division (GO:0140014) |
131 |
8 |
17.5 |
2.38E−04 |
Ube2c, Aurkb, Pttg1, Knstrn, Tpx2, Kiff22, Cdc20, Spag5 |
Sister chromatid segregation (GO:0000819) |
119 |
7 |
16.86 |
2.42E−03 |
Ube2c, Pttg1, Knstrn, Bub1b, Kif22, Cdc20, Spag5 |
Spindle organization (GO:0007051) |
122 |
7 |
16.44 |
2.86E−03 |
Ube2c, Cep72, Knstrn, Stmn1, Tpx2, Cdc20, Spag5 |
Nuclear division (GO:0000280) |
263 |
11 |
11.99 |
2.35E−05 |
Ube2c, Aurkb, Rad51, Pttg1, Knstrn, Bub1b, Tpx2, Kiff22, Cdc20, Spag5 |
Regulation of nuclear division (GO:0051783) |
170 |
7 |
11.8 |
2.55E−02 |
Ube2c, Tnf, Dusp1, Pttg1, Bub1b, Cdc20, Ifg1 |
Mitotic cell cycle process (GO:1903047) |
395 |
16 |
11.61 |
5.61E−09 |
Ube2c, Aurkb, Iqgap3, Rad51, Kif20a, Pttg1, Knstrn, Bub1b, Stmn1, Cdkn3, Tpx2, Kiff22, Ier3, Cdc20, Spag5 |
Mitotic cell cycle (GO:0000278) |
457 |
18 |
11.29 |
2.58E−10 |
Ube2c, Aurkb, Iqgap3, Nuf1, Rad51, Kif20a, Pttg1, Cenpw, Knstrn, Bub1b, Stmn1, Cdkn3, Tpx2, Kiff22, Ier3, Cdc20, Spag5 |
Organelle fission (GO:0048285) |
294 |
11 |
10.72 |
7.35E−05 |
Ube2c, Aurkb, Rad51, Pttg1, Knstrn, Bub1b, Tpx2, Kif22, Cdc20, Spag5 |
|
Control vs 7 days |
|
Antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) |
29 |
4 |
46.22 |
2.11E−02 |
RT1-T24-4, RT1-CE10, RT1-CE5, RT1-CE5 |
Antigen processing and presentation of peptide antigen (GO:0048002) |
47 |
6 |
42.78 |
7.93E−05 |
RT1-T24-4, RT1-CE10, RT1-CE5, Cd74, RT1-CE5, RT1-Da |
Antigen processing and presentation (GO:0019882) |
79 |
6 |
25.45 |
1.66E−03 |
RT1-T24-4, RT1-CE10, RT1-CE5, Cd74, RT1-CE5, RT1-Da |
Cell adhesion (GO:0007155) |
654 |
11 |
5.64 |
3.79E−02 |
Itgae, Tnf, Gpnmb, Axl, Rom1, Cd63, Mfge8, Cldn1, Lgals3bp, Cdh17, Cd96 |
Biological adhesion (GO:0022610) |
663 |
11 |
5.56 |
4.32E−02 |
Itgae, Tnf, Gpnmb, Axl, Rom1, Cd63, Mfge8, Cldn1, Lgals3bp, Cdh17, Cd96 |
Immune response (GO:0006955) |
798 |
13 |
5.46 |
6.23E−03 |
Fut7, Tnf, RT1-T24-4, Cfb, Cxcl13, Cldn1, RT1-CE5, Cd74, Cdh17, RT1-CE5, Skap1, RT1-Da |
Cell surface receptor signaling pathway (GO:0007166) |
1,591 |
18 |
3.79 |
6.48E−03 |
Itgae, Tnf, Card14, Axl, Csf2ra, Sulf1, Evc, Rom1, Cd63, Adgre5, Cxcl13, PLxnc1, Cxcr6, Cxcr3, Cd74, Cdh17, Cd3e, Skap1 |
Immune system process (GO:0002376) |
1,607 |
18 |
3.75 |
7.50E−03 |
Ctnnbl1, Fut7, Tnf, Axl, RT1-T24-4, Cfb, Ifitm1, Cxcl13, Cldn1. RT1-CE10. Cxcr3, RT1-CE5, Cd74, Cdh17, RT1-CE5 Cd3e, Skap1, RT1-Da |